Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort
- 10 November 2024
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 77 (1) , 61-68
Abstract
Objective: The aim of this study was to determine the impact of season, temperature and humidity on the severity of Raynaud phenomenon (RP) in systemic sclerosis.Methods: Data from the Australian Scleroderma Cohort Study were used to assess associations of patient‐reported worsened RP in the month preceding each study visit. Mean monthly weather data were obtained from the closest weather station to the patient's address. We evaluated the relationship between worsened RP and health‐related quality of life (HRQoL) measured using the Short Form 36 instrument.Results: Among 1,972 patients with systemic sclerosis, RP was a near‐universal finding, and worsened RP in the preceding month was reported in 26.7% of 9,175 visits. “Worsened RP” showed significant environmental variability. On multivariable analysis, worsened RP was associated with low mean maximum temperatures (odds ratio [OR] 0.91, 95% confidence interval [95% CI] 0.90–0.92, P < 0.001), high relative humidity (OR 1.05, 95% CI 1.04–1.05, P < 0.001) and lower mean daily evaporation (OR 0.77, 95% CI 0.73–0.81, P < 0.001). Worsened RP was strongly associated with telangiectasia, calcinosis, and digital ulceration, as well as demonstrating an association with anticentromere antibody and gastroesophageal reflux disease and a negative correlation with diffuse disease. Worsened RP was also strongly associated with worse HRQoL.Conclusion: Lower environmental temperature and higher relative humidity had significant associations with worsened RP in this systemic sclerosis cohort, suggesting an important role for dry warmth in managing this condition.Keywords
Funding Information
- St Vincent's Hospital Melbourne (Research Endowment Fund)
- National Health and Medical Research Council (GNT1176538, GNT2013842, GNT1197169)
- Boehringer Ingelheim
- Scleroderma Victoria
- Arthritis Australia
- Janssen Pharmaceutica
This publication has 18 references indexed in Scilit:
- Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysisRheumatology, 2021
- Raynaud phenomenon and digital ulcers in systemic sclerosisNature Reviews Rheumatology, 2020
- Scleroderma in Cairns: an epidemiological studyInternal Medicine Journal, 2019
- The patient experience of Raynaud’s phenomenon in systemic sclerosisRheumatology, 2018
- Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosisAutoimmunity Reviews, 2011
- Cigarette smoking in patients with systemic sclerosisArthritis & Rheumatism, 2010
- Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrumentArthritis Care & Research, 2009
- Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 2007
- Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosisRheumatology, 2006
- Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptomsClinical Rheumatology, 2004